Polycyclic aromatic hydrocarbons (PAHs) have frequently
been suspected
of governing crude oil toxicity because of similar morphological defects
in fish. However, PAH concentrations are often not high enough to
explain the observed crude oil toxicity. We hypothesize that one PAH
can enhance the metabolism and toxicity of another PAH when administered
as a mixture. Early life stage Atlantic haddock (Melanogrammus
aeglefinus) were in this study exposed to phenanthrene
in the presence and absence of 3-methylchrysene that is known to induce
the metabolic enzyme cytochrome P450 1A via cyp1a gene expression. Uptake, metabolism, and multiple toxicity endpoints
were then measured in a time-course study up to 3 days post-hatching.
Passive dosing provided aqueous concentrations ≈180 μg/L
for phenanthrene and ≈0.6 μg/L for 3-methylchrysene,
which resulted in tissue concentrations ≈60 μg/g ww for
phenanthrene and ≈0.15 μg/g ww for 3-methylchrysene.
The low concentration of 3-methylchrysene led to the elevated expression
of cyp1a but no toxicity. Levels of phenanthrene
metabolites were 5-fold higher, and morphological defects and cardiotoxicity
were consistently greater when co-exposed to both compounds relative
to phenanthrene alone. This work highlights the metabolic activation
of PAH toxicity by a co-occurring PAH, which can lead to excess toxicity,
synergistic effects, and the overproportional contribution of PAHs
to crude oil toxicity.